The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nucleic acid labelling market is expected to exhibit a CAGR of 8.29% during 2022-2027.
Nucleic acids refer to complex molecules that are used for transferring genetic information which directs all cellular functions. Some of the major types of these molecules include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). These nucleic acids are generally labeled with tags to facilitate the identification and purification processes. Some of the most commonly used nucleic acid labeling techniques include the incorporation of radioactive phosphates, fluorescent tags and modifications with biotin. These chemical and enzymatic methods are widely used for a vast array of biotechnology and life sciences applications.
The market is primarily driven by the increasing utilization of nucleic acid-based diagnostics for disease risk management, disease diagnostics and prenatal testing across the healthcare sector. This is being supported by the rising incidences of genetic disorders across the globe which has impelled the demand for nucleic acid analytics in the sector. Along with this, there has been an escalating preference for personalized medicines that offer tailor-made therapies to individual patients. Facilitated by the increasing focus on patient-centered approaches, this has created numerous opportunities for genetic medicine and novel technologies, thereby creating a positive outlook for the nucleic acid labeling market. The market is further driven by the rapid advancements in nanotechnology that has led to the continual developments across point-of-care (POC)-based nucleic acid detection. Some of the other factors further contributing to the market growth include the increasing research and development (R&D) activities in the field of genomic research and disease diagnosis and the rising healthcare expenditure across the globe.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid labelling market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, labeling type, method, application and sector.
Breakup by Product:
Breakup by Labeling Type:
Breakup by Method:
Breakup by Application:
Breakup by Sector:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cytiva (Danaher Corporation), Enzo Biochem Inc., F. Hoffmann LA-Roche AG (Roche Holding AG), Merck KGaA, New England Biolabs (UK) Ltd., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc. and Vector Laboratories.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Labeling Type, Method, Application, Sector, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Agilent Technologies Inc., Cytiva (Danaher Corporation), Enzo Biochem Inc., F. Hoffmann LA-Roche AG (Roche Holding AG), Merck KGaA, New England Biolabs (UK) Ltd., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc. and Vector Laboratories|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at